Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
FO2-H82E8 | Human | Biotinylated Human FOLR2 Protein, His,Avitag™ | ![]() |
![]() ![]() |
![]() ![]() ![]() ![]() |
FO2-C52H8 | Cynomolgus | Cynomolgus FOLR2 Protein, His Tag | ![]() |
![]() ![]() |
![]() ![]() |
FO2-H5223 | Human | Human FOLR2 Protein, His Tag | ![]() |
![]() ![]() |
![]() ![]() ![]() ![]() |
Immobilized Folic acid-BSA on CM5 Chip can bind Biotinylated Human FOLR2, His,Avitag (Cat. No. FO2-H82E8) with an affinity constant of 4.61 nM as determined in a SPR assay (Biacore T200) (Routinely tested).
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Vintafolide | EC-145; MK-8109 | Phase 2 Clinical | Novartis Pharma Ag | Ovarian Neoplasms; Solid tumours; Adenocarcinoma of Lung; Breast Neoplasms; Endometrial Neoplasms; Carcinoma, Non-Small-Cell Lung | Details |
Arfolitixorin | ISO-901; 6R-MTHF | Phase 3 Clinical | Isofol Medical Ab | Rectal Neoplasms; Colonic Neoplasms; Osteosarcoma; Colorectal Neoplasms | Details |
This web search service is supported by Google Inc.